Advice
in the absence of a submission from the holder of the marketing authorisation
dapoxetine hydrochloride (Priligy®) is not recommended for use within NHS Scotland.
Indication under review: treatment of premature ejaculation (PE) in adult men aged 18 to 64 years.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice110KB (PDF)
Medicine details
- Medicine name:
- dapoxetine (Priligy)
- SMC ID:
- 987/14
- Indication:
- Treatment of premature ejaculation (PE) in adult men aged 18 to 64 years.
- Pharmaceutical company
- A Menarini Pharmaceuticals UK Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 07 July 2014